BITPRISMIA
Coinbase has announced support for Bio Protocol (BIO) on the Ethereum network, marking a significant milestone for the project and offering new opportunities for crypto investors.
180 Life Sciences is shifting its focus to Ethereum by raising $425 million through a PIPE transaction to acquire ETH for its corporate treasury and rebranding as ETHZilla Corporation, signaling a significant corporate embrace of cryptocurrency.
Nasdaq-listed biotech firm Windtree Therapeutics plans to raise $520 million for a strategic BNB acquisition, signaling a significant cross-industry investment between biotech and cryptocurrency.
Latent Labs has launched a web-based AI for protein design, backed by $50 million in funding, aiming to democratize biology and accelerate drug discovery by enabling the creation of novel proteins.
A Stanford University study highlights significant risks and stigmatization issues associated with AI therapy chatbots, emphasizing the need for critical evaluation and guidelines in their use for mental health support.
Worldcoin has temporarily halted its iris scan services in Germany due to urgent privacy concerns, raising broader questions about the implications of biometric data collection.
BioSig Technologies, in partnership with Streamex, plans to raise $1.1 billion to tokenize gold as a Real World Asset (RWA) on the Solana Blockchain, signaling mainstream adoption of digital assets.
Changpeng Zhao (CZ), founder of Binance, donated $10 million in BNB to Vitalik Buterin's biotech initiative, highlighting crypto philanthropy's role in supporting open-source biotech and human health.